EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis

Tatiana S Driva iD, Christoph Schatz iD, Johannes Haybaeck

Biomolecules · 16.08.2023 · 13 (8) · 1253

DOI: 10.3390/biom13081253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.08.2023. Verfasst von Tatiana S Driva und 2 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Endometriosis, Ovarian Neoplasms, Carcinoma. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian clear cell (OCCC) and endometrioid (EnOC) carcinomas are often subsumed under the umbrella term “endometriosis-associated ovarian cancer” (EAOC), since they frequently arise from ectopic endometrium settled in the ovaries. The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is known to be aberrantly activated both in endometriosis and EAOC; however, its role in the progression of endometriosis to ovarian cancer remains unclear. In fact, cancer-associated alterations in the mTOR pathway may be found in normal uterine epithelium, likely acting as a first step towards ovarian cancer, through the intermediary stage of endometriosis. This review aims to summarize the current knowledge regarding mTOR signaling dysregulation in the uterine endometrium, endometriosis, and EAOC while focusing on the interconnections between the PI3K/AKT/mTOR pathway and other signaling molecules that give rise to synergistic molecular mechanisms triggering ovarian cancer development in the presence of endometriosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisOvarian NeoplasmsCarcinomaFemaleHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesPhosphatidylinositol 3-Kinase

Stichwörter der Autor:innen

ARID1A mutationsPI3K/AKT/mTOR pathwayendometriosisendometriumovarian cancer

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesPhosphatidylinositol 3-Kinase

Autor:innen und Institutionen

  • First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Diagnostic & Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, 8010 Graz, Austria.

ORCID-Profile: Tatiana S Driva, Christoph Schatz

Zitieren

APA

Driva, T. S., Schatz, C., & Haybaeck, J. (2023). Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. Biomolecules, 13(8), 1253. https://doi.org/10.3390/biom13081253

Vancouver

Driva TS, Schatz C, Haybaeck J. Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. Biomolecules. 2023;13(8):1253. doi:10.3390/biom13081253

BibTeX
@article{Driva2023,
  author = {Driva, Tatiana S and Schatz, Christoph and Haybaeck, Johannes},
  title = {Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {8},
  pages = {1253},
  doi = {10.3390/biom13081253}
}
Kostenlos starten →